OPT cheaper today than in 2019 ahead of P2b, page-25

Well Primaus you’ve been pretty much on the money as to where the stock price has been trending in recent time so hopefully you’re on the money this time too.

On a another note I got around to watching the EF Hutton webinar. The slide pack of the presentation is largely a reproduction of previous recent presentations. The webinar itself covered a bit more territory, but the Q+A session which ran for a good 20 mins at the end of the presentation was the most interesting part. Megan Baldwin was quizzed on amongst other things, how confident they were of finishing recruitment within the currently indicated time frame, as well as the company’s funding situation. She portrayed a strong level of confidence recruitment would be completed as per current guidance. With regard to funding we were told the company has sufficient funds to cover up to trial readouts.
In my mind there is an extreme dichotomy as to where the share price currently sits versus the actual progress the company has made, and is making towards getting the appropriate staffing and infrastructure in place in readiness for the commercial launch of Opt-302 pending successful trial outcomes.